EN | RU
EN | RU

Help Support

Back

Recognition of treatment effect modifiers in the STarT Back Trial

Recognition of treatment effect modifiers in the STarT Back Trial Recognition of treatment effect modifiers in the STarT Back Trial
Recognition of treatment effect modifiers in the STarT Back Trial Recognition of treatment effect modifiers in the STarT Back Trial

What's new?

As per a research study, SES, educational level, and number of pain medications has been described as the potential treatment effect attributes for LBP prognostic stratified care.

One of the foremost low back pain (LBP) research priority is the depiction of patient characteristics influencing treatment outcomes. The patient characteristics associated with treatment response have not yet been discovered although the outcomes from the STarT Back trial support the effectiveness of prognostic stratified care for LBP in contrast to the current best care.

This is a secondary analysis whose purpose was to recognise  treatment effect modifiers within the STarT Back trial at 4-month follow-up (n = 688). Using the Roland-Morris Disability Questionnaire (≥7), the treatment response was dichotomized using back-specific physical disability. Previous litrature was used to recognise the candidate modifiers. These were estimated using logistic regression with statistical interaction terms to supply preliminary evidence of treatment effect modification. The socioeconomic status (SES) was recognised as an effect modifier for disability outcomes (odds ratio [OR] = 1.71, P = .028). High SES patients getting prognostic stratified care were 2.5 times less likely to have a poor outcome compared with low SES patients getting principal current care (OR = .40, P = .006). Education level (OR = 1.33, P = .109) and number of pain medications (OR = .64, P = .140) met the standards for effect modification with weaker confirmation (.20 > P ≥ .05). These discoveries supplement preliminary evidence for SES, education, and number of pain medications as treatment effect modifiers of prognostic stratified care furnished in the STarT Back Trial.

Hence, this analysis provides preliminary exploratory findings about the characteristics of patients who might least likely advantage from targeted treatment via prognostic stratified care for LBP.

Source:

Science Direct

Article:

Identifying Treatment Effect Modifiers in the STarT Back Trial: A Secondary Analysis

Authors:

Jason M. Beneciuk et al.

Comments (0)

Recommendations

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies ru en
Try: